- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: antibodies, monoclonal, humanized
Total 525 results
-
Shanghai Junshi Bioscience Co., Ltd.CompletedHypercholesterolemiaChina
-
The First Affiliated Hospital of Nanchang UniversityUnknownRelapsed or Refractory Multiple MyelomaChina
-
Bio-Thera SolutionsUnknownHER2-Positive Solid TumorsChina
-
Genor Biopharma Co., Ltd.Unknown
-
CelgeneCompletedMetastatic Breast CancerUnited States
-
Genor Biopharma Co., Ltd.Unknown
-
Genor Biopharma Co., Ltd.UnknownHER-2-positive Advanced Breast CancerChina
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.UnknownMelanoma | Urological CancerChina
-
Peking UniversityUnknown
-
Northwestern UniversityGenentech, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Case Comprehensive Cancer CenterCompletedProstate CancerUnited States
-
RemeGen Co., Ltd.CompletedAdvanced Cancer | Urothelial CarcinomaChina
-
Livzon Pharmaceutical Group Inc.Completed
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Henlix, IncTerminated
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)NRG Oncology; Radiation Therapy Oncology GroupCompletedGlioblastoma | Gliosarcoma | Supratentorial GlioblastomaUnited States, Canada, Israel
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Endometrial CarcinomaUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedCervical Squamous Cell Carcinoma | Recurrent Cervical CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Endometrial CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedMalignant Ovarian Epithelial Tumor | Ovarian Gynandroblastoma | Ovarian Sertoli-Leydig Cell Tumor | Ovarian Sex Cord Tumor With Annular Tubules | Ovarian Steroid Cell Tumor | Ovarian Granulosa Cell Tumor | Ovarian Sex Cord-Stromal Tumor | Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell...United States
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous... and other conditionsUnited States, Korea, Republic of, Canada, Japan
-
National Cancer Institute (NCI)NRG OncologyCompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Stage IVB Cervical CancerUnited States, Spain
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditionsUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditionsUnited States, Japan
-
Peking UniversityShanghai Junshi Bioscience Co., Ltd.Completed
-
University Hospital, BrestUnknownBreast Neoplasms | HER-2 Gene AmplificationFrance
-
National Cancer Institute (NCI)CompletedRectal Adenocarcinoma | Stage III Rectal Cancer AJCC v7 | Stage II Rectal Cancer AJCC v7United States
-
National Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Endometrial Serous Adenocarcinoma | Lung Carcinoid Tumor | Metastatic... and other conditionsUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Breast Cancer Research FoundationCompletedBreast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedPancreatic CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedCarcinoma, Non-Small-Cell Lung | Lung AdenocarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
St. Jude Children's Research HospitalCURE Childhood Cancer, Inc.Completed
-
National Cancer Institute (NCI)CompletedBevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney CancerClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v7United States, Peru
-
City of Hope Medical CenterAddario Lung Cancer Medical InstituteWithdrawnExtensive Stage Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal... and other conditionsUnited States
-
Institut Paoli-CalmettesInnate PharmaUnknownHematologic MalignanciesFrance
-
National Cancer Institute (NCI)Radiation Therapy Oncology Group; American College of Radiology Imaging NetworkCompletedAdult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States
-
GlaxoSmithKlineWithdrawnAutoimmune DiseasesUnited Kingdom
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 2 | Vestibular SchwannomaUnited States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Gilead SciencesCompletedHER2 Negative Breast Carcinoma Expressing CEAFrance